Navigation Links
PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
Date:4/23/2008

First Registration Study of an Investigational Drug for Duchenne/Becker

Muscular Dystrophy

SOUTH PLAINFIELD, N.J., April 23 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC), today announced the initiation of an international pivotal trial of PTC124 in patients with Duchenne/Becker muscular dystrophy (DMD/BMD) due to a nonsense mutation. The primary objective of this registration-directed Phase 2b trial is to demonstrate the efficacy of PTC124 as measured by improvements in the walking ability of patients with this progressive genetic disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

"DMD/BMD is a disorder with a significant need for better treatment options, and we are very encouraged by the promising results we have seen to date with PTC124," said Brenda Wong, M.D., Associate Professor of Pediatrics and Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, who was involved in the Phase 2a study and is one of the trial's lead investigators. "We believe that the safety profile of PTC124 and activity we have seen in the Phase 2a studies clearly support the initiation of this longer-term, registration-directed efficacy and safety study. We are very pleased to be a part of this groundbreaking trial."

Patients with DMD and BMD are boys and young men who lack dystrophin, a protein that is critical to the structural stability of muscle fibers. Patients develop progressive muscle weakness that leads to loss of ambulation, wheelchair dependency, and eventual decline in respiratory and cardiac function. It is estimated that one in 10 DMD patients are likely to have a Becker presentation, a milder form of the disease that is associated with later manifestation of symptoms. In essence, DMD and BMD represent a continuum of the same disease.

PTC124 is a novel, orally delivered drug in development f
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
2. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
3. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... PRUSSIA, Pa. , March 30, 2015 /PRNewswire/ ... European Medicines Agency (EMA) has started the Centralized ... (MAA) for its long-acting fusion protein linking recombinant ... European Commission approval, rIX-FP will provide hemophilia B ... as the European Economic Area (EEA) countries, with ...
(Date:3/30/2015)... , March 30, 2015 Sorrento Therapeutics, ... of George K. Ng to the position ... this capacity, Mr. Ng will be responsible for all ... Ng joins the Company from BioDelivery Sciences International, Inc., ... and a member of senior management that led that ...
(Date:3/30/2015)... March 30, 2015  BioPharmX Corporation (OTCQB: BPMX), ... of novel drug delivery products to address unmet ... announced the appointment of Stephen Morlock , ... to its board of directors.  Mr. Morlock,s background ... expand its national roll-out of Violet iodine, the ...
Breaking Medicine Technology:European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
... announces that a new market research report is available ... Markets and Companies http://www.reportlinker.com/p0203546/Neuroprotection---Drugs-Markets-and-Companies.html ... neuroprotection in acute disorders such as stroke and injuries ... diseases such as neurodegenerative disorders because many of the ...
... Amarin Corporation plc (Nasdaq: AMRN ) has scheduled ... am Eastern Time (4:00 pm UTC/GMT) to discuss selected financial ... update of the Company,s MARINE and ANCHOR trials, the two ... AMR101 for treating elevated triglyceride levels in separate patient populations. ...
Cached Medicine Technology:Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 2Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 3Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 4Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 5Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 6Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 7Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 8Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 9Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 10Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 11Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 12Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 13Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 14Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 15Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 16Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 17Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 18Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 19Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 20Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010 2
(Date:3/30/2015)... March 31, 2015 Healtheminds, a start-up ... services through an innovative, easy to use and engaging ... create awareness about mental health related issues. The first ... to alcohol, tobacco and other drugs. , Consumption ... health effects. These include the toxic effects of excessive ...
(Date:3/30/2015)... Wright & Schulte LLC, who is currently ... number of Syngenta corn lawsuits now pending ... Court, District of Kansas, have risen sharply since the ... update released by the U.S. Judicial Panel on Multidistrict ... lawsuits are now consolidated in the federal litigation, all ...
(Date:3/30/2015)... Southern Med Law, a law firm ... has filed a Mirena IUD lawsuit on ... his premature birth in 2012. The complaint, which is ... the Mirena IUD failed to prevent pregnancy due to ... difficult to remove. The inability to remove the IUD ...
(Date:3/30/2015)... 30, 2015 “We are pleased to ... Awards on May 30 in Los Angeles,” said Mark ... volunteers pilots nominated from a nationwide call for nominations. ... Angel Flight Mid-Atlantic, Richard Durden with LightHawk and Stephen ... by the award recipients will receive a $15,000 contribution ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical ... it is expanding its services into Asia in 2015. ... the world comes at a time when Asia’s strengthening ... better healthcare. A rapidly growing aging population and changing ... in medicine in Asia. “We are excited to be ...
Breaking Medicine News(10 mins):Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:2015 Endeavor Awards Recipients Announced 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2
... of doses, lack of protocols for this screening test , ... coronary calcium scan is worth the risk, a new study ... easy. , A team of researchers from the U.S. National ... of radiation exposure from having such a screening test every ...
... Cindy Schwartz, MD, of Hasbro Children,s Hospital has identified ... patients. The new treatment enhances efficacy through dose-dense drug ... high cumulative dose chemotherapy. Schwartz and the researchers of ... the journal Blood (posted in an online ...
... ... the International Stevie Award for Communications Team of the Year for their work on Hear ... loss. , ... July 13, 2009 -- Leading hearing system manufacturer Phonak has won the International Stevie Award ...
... , , , ... one of the nation,s leading consumer-focused private equity firms, today ... StriVectin brand and related assets from affiliates of Klein-Becker. ... care industry, led by Chief Executive Officer Melisse Shaban and ...
... ... in media relations services, explains how PR professionals can add a vital dimension to their ... of Twitter followers (Tweetups). , ... Livingston, NJ (PRWEB) July 13, 2009 -- A white paper just issued by BurrellesLuce ...
... , NEW YORK, July 13 Next week, the Center ... clinics in six states demonstrating that attacks, harassment, discriminatory legal restrictions and ... women,s reproductive rights. The report will be released at a briefing ... July 22 , at 12:30 p.m. in ...
Cached Medicine News:Health News:Coronary Calcium Scans Can Raise Cancer Risks 2Health News:Coronary Calcium Scans Can Raise Cancer Risks 3Health News:Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks 2Health News:Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks 3Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 2Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 3Health News:Catterton Partners Acquires Leading Cosmeceutical Brand StriVectin 2Health News:Catterton Partners Acquires Leading Cosmeceutical Brand StriVectin 3Health News:BurrellesLuce White Paper Gives Advice on Turning Twitter Connections Into Community Building Blocks 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: